Home › Funds › PARK CIRCLE Co › VRTX

PARK CIRCLE Co position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

PARK CIRCLE Co reported holding 2,764 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 1.30% of its reported portfolio and ranking #19 among its reported holdings. PARK CIRCLE Co has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)2.76K sh
Reported value held$1.45M
Portfolio Weight1.30%
First reportedQ4 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PARK CIRCLE Co's VRTX position evolved

PARK CIRCLE Co first disclosed a stake in VRTX in Q4 2023 at 2,764 shares (US$1.1M). The position peaked in Q3 2026 at 2,764 shares, worth US$1.4M. Across 12 filings, PARK CIRCLE Co held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,764 shares valued at US$1.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 2.76K $1.12M New
Q1 2024 2.76K $1.16M Hold
Q2 2024 2.76K $1.30M Hold
Q3 2024 2.76K $1.29M Hold
Q4 2024 2.76K $1.11M Hold
Q1 2025 2.76K $1.34M Hold
Q2 2025 2.76K $1.23M Hold
Q3 2025 2.76K $1.08M Hold
Q4 2025 2.76K $1.25M Hold
Q1 2026 2.76K $1.23M Hold
Q2 2026 2.76K $1.37M Hold
Q3 2026 2.76K $1.45M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has PARK CIRCLE Co held VRTX?

PARK CIRCLE Co has disclosed VRTX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is PARK CIRCLE Co's current position in VRTX?

As of Q3 2026, PARK CIRCLE Co holds 2.76K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $1.45M, representing 1.30% of its reported portfolio and ranking #19.

Has PARK CIRCLE Co been buying or selling VRTX?

In the latest 13F filing (Q3 2026), PARK CIRCLE Co held unchanged its position in VRTX. The position peaked in Q3 2026 at 2.76K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.